Benvenue Medical Enrolls Patients in LIFT Study for Degenerative Disc Disease

Benvenue Medical in Santa Clara, Calif., a developer of minimally invasive solutions for spine repair, has announced the active enrollment of patients in the Luna Interbody System for Fusion Trial.

Advertisement

LIFT is a European post-market, multi-center, prospective, non-randomized single-arm study aimed at collecting clinical data on the effectiveness of Luna Interbody Spacer System in spinal fusion procedures for degenerative disc disease. The system is designed to address the implant challenges for a true minimally invasive approach to spinal fusion by providing spine surgeons more flexibility in implantation.

The trail will ultimately include 100 spine patients at eight sites in Germany, Belgium, Ital and the UK. After enrollment is complete, the Luna Interbody Spacer System will be commercially available in the EU. Currently the device is not available in the United States but Benevenue Medical intends to submit at 510(k) in the U.S. later this year.

More Articles on Spine Studies:

Early Decompression May Improve Neurologic Outcomes After Spinal Cord Injury
10 Recent Spine Studies & Research Findings
Researchers: BMP Doesn’t Improve Long-Term Outcomes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spine

Advertisement

Comments are closed.